switching between glp-1 agonists Frontiers How GLP-1 Receptor Agonists Evolved
Description
Despite these favorable mechanisms, concerns remain regarding the impact of GLP-1 RAs on lean body mass (LBM) and the potential risk of sarcopenia
Management of hyperglycaemia in type 2 diabetes, 2022
See a healthcare provider immediately if you experience: An inability to eat Persistent or severe nausea that impacts your daily life Signs of dehydration (extreme thirst, dizziness, dry mouth, peeing less often) If your nausea is severe, consult with your prescribing physician or your GI team
In metabolic dysfunction-associated steatotic liver disease, GLP-1RAs reduce hepatic steatosis and fibrosis by modulating inflammation in hepatocytes and Kupffer cells
Thus, these post marketing data may be useful to complement findings from other study designs, but cannot be safely interpreted in isolation
